Capricor Therapeutics CAPR
NASDAQ CAPR
$5.88 -0.73 (-11.04%)
At close: Oct 21, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Receivables (2023 - 2025)

Updated

Capricor Therapeutics (CAPR) recorded Receivables of $59,167 in Q4 2025, down 99.8% from $30.37 million a year earlier.

Analysis

Capricor Therapeutics (CAPR) Receivables (2023 - 2025) Analysis & Trends

  • Across earlier years, Receivables came in at $30.37 million in FY2024 (+49.1%) and $20.37 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Capricor Therapeutics 339.74 Mn -593.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 59,167.00
Dec 31, 2024 30.37 Mn
Dec 31, 2023 20.37 Mn
API Access

Capricor Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=CAPR&period=max&api_key=YOUR_API_KEY